Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD.
暂无分享,去创建一个
K. Propert | N. Nissen | E. Henderson | M. Green | A. Gottlieb | B. Peterson | G. Canellos | M. Cooper | J. Anderson | James R. Anderson
[1] A. Hagenbeek,et al. Management of relapse and survival in advanced stage Hodgkin's disease: the EORTC experience. , 1991, Annals of oncology : official journal of the European Society for Medical Oncology.
[2] M. Gore,et al. Ch1vpp Combination Chemotherapy for Hodgkin's Disease: Long Term Results , 2022 .
[3] B. Clarkson,et al. Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] C. Haanen,et al. Dose intensity of MOPP chemotherapy and survival in Hodgkin's disease. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] M Tubiana,et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] T. Lister,et al. Prognostic factors for survival in stage IIIB and IV Hodgkin's disease: a multivariate analysis comparing two specialist treatment centres. , 1988, British Journal of Cancer.
[7] M. Tucker,et al. Risk of second cancers after treatment for Hodgkin's disease. , 1988, The New England journal of medicine.
[8] Flavio Crippa,et al. Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] E. Jaffe,et al. Twenty years of MOPP therapy for Hodgkin's disease. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] A. Santoro,et al. Second acute leukemia and other malignancies following treatment for Hodgkin's disease. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] A. Santoro,et al. Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results. , 1986, Annals of internal medicine.
[12] J. Connors,et al. MOPP/ABV hybrid program: combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin's disease. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] A. Santoro,et al. Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD. , 1985, European journal of cancer & clinical oncology.
[14] D. Johnston,et al. Prognostic factors for stage IV Hodgkin's disease treated with MOPP, with or without bleomycin , 1985, Cancer.
[15] G. Rosner,et al. BCVPP chemotherapy for advanced Hodgkin's disease: evidence for greater duration of complete remission, greater survival, and less toxicity than with a MOPP regimen. Results of the Eastern Cooperative Oncology Group study. , 1984, Annals of internal medicine.
[16] S. Rosenberg,et al. Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe. , 1984, Annals of internal medicine.
[17] S. Rosenberg,et al. A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] T. Lister,et al. Gonadal function in Hodgkin's disease: long-term follow-up of chemotherapy. , 1982, British medical journal.
[19] F. Mandelli,et al. Treatment of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD). , 1982, European Journal of Cancer and Clinical Oncology.
[20] R. Schilsky,et al. Long-term follow up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's disease. , 1981, The American journal of medicine.
[21] M. Pike,et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.
[22] G. Bonadonna,et al. Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP , 1975, Cancer.
[23] J. Fleiss,et al. Statistical methods for rates and proportions , 1973 .
[24] V. Devita,et al. Combination chemotherapy in the treatment of advanced Hodgkin's disease. , 1970, Annals of internal medicine.